Less Pain, More Gain: Buprenorphine-Naloxone and Patient Retention in Treatment

Author： Renzelli Cara M.   Capretto Neil A.  

Publisher： Haworth Press

ISSN： 1055-0887

Source： Journal of Addictive Diseases, Vol.25, Iss.3, 2006-08, pp. : 97-104

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Spotlight on Buprenorphine/Naloxone in the Treatment of Opioid Dependence†

By Orman Jennifer S.   Keating Gillian M.  

CNS Drugs, Vol. 23, Iss. 10, 2009-10 ,pp. : 899-902

Adis International

Access to resources Recommend Favorite

Pharmacokinetic Interactions between Buprenorphine/Naloxone and Raltegravir in Subjects Receiving Chronic Buprenorphine/Naloxone Treatment

By Douglas Bruce R.  

The American Journal of Drug and Alcohol Abuse, Vol. 39, Iss. 2, 2013-03 ,pp. : 80-85

Informa Healthcare

Access to resources Recommend Favorite

Buprenorphine/Naloxone: A Review of its Use in the Treatment of Opioid Dependence

By Orman Jennifer S.   Keating Gillian M.  

Drugs, Vol. 69, Iss. 5, 2009-03 ,pp. : 577-607

Adis International

Access to resources Recommend Favorite

Buprenorphine/naloxone reduces drug abuse, costs

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 552, 2008-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Buprenorphine and Buprenorphine/Naloxone Diversion, Misuse, and Illicit Use: An International Review

By  

Current Drug Abuse Reviews, Vol. 4, Iss. 1, 2011-03 ,pp. : 28-41

Bentham Science Publishers

Access to resources Recommend Favorite